The use of electroconvulsive therapy in a patient with juvenile systemic lupus erythematosus and catatonia

Lupus

Volumn 21, Issue 14, 2012, Pages 1575-1581

  Mon, T ^a   L'Ecuyer, S ^b   Farber, N B ^a   White, A J ^c   Baszis, K W ^c   Hearn, J K ^a   Spiegel, T E ^a   French, A R ^c   Kitcharoensakkul, M ^c  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Ranken Jordan A Pediatric Specialty Hospital   (United States)

^c ST LOUIS CHILDREN S HOSPITAL   (United States)

Author keywords

catatonia; ECT; neuropsychiatric lupus

Indexed keywords

AMANTADINE; ANTINUCLEAR ANTIBODY; C REACTIVE PROTEIN; CYCLOPHOSPHAMIDE; DIAZEPAM; DOUBLE STRANDED DNA ANTIBODY; ENOXAPARIN; ETOMIDATE; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; LORAZEPAM; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OLANZAPINE; PREDNISOLONE; PREDNISONE; RIBONUCLEOPROTEIN ANTIBODY; RITUXIMAB; RO ANTIBODY; SUXAMETHONIUM;

ADOLESCENT; AGITATION; ALOPECIA; ARTHRALGIA; ARTICLE; BLOOD PRESSURE MEASUREMENT; BRAIN CORTEX; CASE REPORT; CATATONIA; CERVICAL LYMPH NODE; COMPUTER ASSISTED TOMOGRAPHY; COOMBS POSITIVE HEMOLYTIC ANEMIA; DEEP VEIN THROMBOSIS; DISORIENTATION; DRUG PULSE THERAPY; ELECTROCONVULSIVE THERAPY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FEVER; HUMAN; HYPERGAMMAGLOBULINEMIA; HYPOCOMPLEMENTEMIA; IMMUNOSUPPRESSIVE TREATMENT; LABORATORY TEST; LEUKOCYTE COUNT; LUMBAR PUNCTURE; MENTAL HEALTH; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PERSECUTORY DELUSION; PLASMAPHERESIS; PRIORITY JOURNAL; SWELLING; SYSTEMIC LUPUS ERYTHEMATOSUS; TACHYCARDIA; THROMBOCYTE COUNT; TREATMENT DURATION;

ADOLESCENT; AGE OF ONSET; CATATONIA; ELECTROCONVULSIVE THERAPY; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS VASCULITIS, CENTRAL NERVOUS SYSTEM; TREATMENT OUTCOME;

EID: 84869456551     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203312464803     Document Type: Article

References (37)

1. Diagnostic and statistical manual of mental disorders. 4 th ed. Washington, DC: APA, 2000. Washington, DC: APA ; 2000 :
2. Popescu A, Kao AH. Neuropsychiatric systemic lupus erythematosus. Curr Neuropharmacol. 2011 ; 9: 449-457
3. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999; 42: 599-608.
4. Guze SB. The occurrence of psychiatric illness in systemic lupus erythematosus. Am J Psychiatry. 1967 ; 123: 1562-1570
5. Brey RL, Holliday SL, Saklad AR, et al. Neuropsychiatric syndromes in lupus: Prevalence using standardized definitions. Neurology. 2002 ; 58: 1214-1220
6. Mac DS, Pardo MP. Systemic lupus erythematosus and catatonia: A case report. J Clin Psychiatry. 1983 ; 44: 155-156
7. Brelinski L, Cottencin O, Guardia D, et al. Catatonia and systemic lupus erythematosus: A clinical study of three cases. Gen Hosp Psychiatry. 2009 ; 31: 90-92
8. Ditmore BG, Malek-Ahmadi P, Mills DM, Weddige RL. Manic psychosis and catatonia stemming from systemic lupus erythematosus: Response to ECT. Convuls Ther. 1992 ; 8: 33-37
9. Sibbitt WL, Brandt JR, Johnson CR, et al. The incidence and prevalence of neuropsychiatric syndromes in pediatric onset systemic lupus erythematosus. J Rheumatol. 2002 ; 29: 1536-1542
10. Muscal E, Brey RL. Neurologic manifestations of systemic lupus erythematosus in children and adults. Neurol Clin. 2010 ; 28: 61-73
11. Hesslinger B, Walden J, Normann C. Acute and long-term treatment of catatonia with risperidone. Pharmacopsychiatry. 2001 ; 34: 25-26
12. Cook EH, Olson K, Pliskin N. Response of organic catatonia to risperidone. Arch Gen Psychiatry. 1996 ; 53: 82-83
13. Van Den Eede F, Van Hecke J, Van Dalfsen A, Van den Bossche B, Cosyns P, Sabbe BG. The use of atypical antipsychotics in the treatment of catatonia. Eur Psychiatry. 2005 ; 20: 422-429
14. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982 ; 25: 1271-1277
15. Bahro M, Kampf C, Strnad J. Catatonia under medication with risperidone in a 61-year-old patient. Acta Psychiatr Scand. 1999 ; 99: 223-224; discussion 224-226
16. Gugger JJ, Saad M, Smith C. Neuroleptic-induced catatonia in two hospitalized patients. J Pharm Pract. 2012 ; 25: 250-254
17. Lee JW. Neuroleptic-induced catatonia: Clinical presentation, response to benzodiazepines, and relationship to neuroleptic malignant syndrome. J Clin Psychopharmacol. 2010 ; 30: 3-10
18. McKeown NJ, Bryan JH, Horowitz BZ. Catatonia associated with initiating paliperidone treatment. West J Emerg Med. 2010 ; 11: 186-188
19. Parraga H, Harris K. Catatonia under treatment with risperidone. J Dev Behav Pediatr. 2006 ; 27: 369-369
20. Ceylan MF, Kul M, Kultur SE, Kilincaslan A. Major depression with catatonic features in a child remitted with olanzapine. J Child Adolesc Psychopharmacol. 2010 ; 20: 225-227
21. Guzman CS, Myung VH, Wang YP. Treatment of periodic catatonia with atypical antipsychotic, olanzapine. Psychiatry Clin Neurosci. 2008 ; 62: 482-482
22. Babington PW, Spiegel DR. Treatment of catatonia with olanzapine and amantadine. Psychosomatics. 2007 ; 48: 534-536
23. Lanham JG, Brown MM, Hughes GR. Cerebral systemic lupus erythematosus presenting with catatonia. Postgrad Med J. 1985 ; 61: 329-330
24. Perisse D, Amoura Z, Cohen D, et al. Case study: Effectiveness of plasma exchange in an adolescent with systemic lupus erythematosus with catatonia. J Am Acad Child Adolesc Psychiatry. 2003 ; 42: 497-499
25. Marra D, Amoura Z, Soussan N, et al. Plasma exchange in patients with stuporous catatonia and systemic lupus erythematosus. Psychother Psychosom. 2008 ; 77: 195-196
26. Alao AO, Chlebowsk S, Chung C. Neuropsychiatric systemic lupus erythematosus presenting as bipolar I disorder with catatonic features. Psychosomatics. 2009 ; 50: 543-547
27. Reichlin M. Ribosomal P antibodies and CNS lupus. Lupus. 2003 ; 12: 916-918
28. Fam J, Lee TS, Lee HY, Ng BY. Electroconvulsive therapy for catatonia in neuropsychiatric systemic lupus erythematosus. J ECT. 2010 ; 26: 143-144
29. Malur C, Pasol E, Francis A. ECT for prolonged catatonia. J ECT. 2001 ; 17: 55-59
30. Fink M. The intimate relationship between catatonia and convulsive therapy. J ECT. 2010 ; 26: 243-245
31. Rohland BM, Carroll BT, Jacoby RG. ECT in the treatment of the catatonic syndrome. J Affect Disord. 1993 ; 29: 255-261
32. Fink M, Taylor MA Catatonia: A clinician's guide to diagnosis and treatment. Cambridge, UK: Cambridge University Press ; 2003 :
33. Fink M. Failure to use ECT in treatment of catatonia. Am J Psychiatry. 1992 ; 149: 145-146
34. Rhoads JC, Votolato NA, Young JL, Gilchrist RH. The successful use of right unilateral ultra-brief pulse electroconvulsive therapy in an adolescent with catatonia. Brain Stimul. 2010 ; 3: 51-53
35. Palm U, Forsthoff A, de la Fontaine L, et al. Electroconvulsive therapy and corpus callosum aplasia: A case report. J ECT. 2011 ; 27: e17 - e20
36. Dhossche DM, Wachtel LE. Catatonia is hidden in plain sight among different pediatric disorders: A review article. Pediatr Neurol. 2010 ; 43: 307-315
37. Barile-Fabris L, Ariza-Andraca R, Olguín-Ortega L, et al. Controlled clinical trial of IV cyclophosphamide versus IV methylprednisolone in severe neurological manifestations in systemic lupus erythematosus. Ann Rheum Dis. 2005 ; 64: 620-625